What is Imatrex?
Imatrex Inc established its market presence through the development of advanced medical imaging and image-guided radiotherapy equipment. While the organization has transitioned from its original focus on pioneering new hardware, it maintains a vital role in the healthcare ecosystem by providing essential service and maintenance for existing Imatron EBCT Scanners across the United States. This operational pivot highlights the company's enduring legacy in the medical device sector, where it continues to support healthcare facilities and professionals who rely on its specialized diagnostic technology for patient care.
How much funding has Imatrex raised?
Imatrex has raised a total of $1M across 2 funding rounds:
Debt
$350K
Debt
$648K
Debt (2020): $350K with participation from PPP
Debt (2021): $648K led by PPP
Key Investors in Imatrex
PPP
Public-Private Partnership
What's next for Imatrex?
The current strategic posture of Imatrex suggests a focus on operational continuity and the preservation of its installed base. By prioritizing the service and support of legacy EBCT systems, the company ensures that healthcare providers can continue to leverage high-fidelity imaging tools without the immediate need for capital-intensive equipment replacement. Moving forward, the firm's ability to manage these long-term service obligations will remain the cornerstone of its value proposition, balancing its historical innovation with the practical demands of modern clinical environments. The capital secured through its recent financing rounds provides the necessary runway to uphold these service standards while navigating the evolving landscape of medical device maintenance and regulatory compliance.
See full Imatrex company page
